Khiron Life Sciences Corp. KHRNF KHRN A, announced its market entry into Switzerland with initial sales of new products and increases its product offerings in Germany and UK.
In August 2022, Khiron completed the acquisition of its EU GMP-certified manufacturer and wholesaler, Pharmadrug GmbH in Germany. Since then, the company has obtained import and export permits across Germany and the UK bringing to market its new product offerings, as well as looking for opportunities to expand its presence in other European markets.
The Alpine Republic of Switzerland has become the next market for Khiron, with Khiron's established reputation in Germany helping to pave the way. The start of the expansion is marked by the availability of the flower products KHIRON Gelato 19/1 and KHIRON Caramel 5/7.
Recently, a survey was conducted among all patients of Zerenia Clinics UK, with 100% of respondents stating that they are satisfied that their quality of life has improved since starting treatment. This service experience for patients is complemented by Khiron's steadily growing product portfolio, which has just recently been expanded with three additional exclusive varieties that will offer new treatment options for prescribers and patients.
Franziska Katterbach, president of Khiron Europe, stated: "Khiron continues its tradition of entering new markets early and furthering our goal of improving the lives of our patients in all our target markets. We are very excited to improve lives of patients in Switzerland as of now. I am equally pleased that our one-year anniversary of Zerenia Clinics UK is marked by the very good feedback from patients treated in our clinic. This reinforces our patient-first and quality first-approach which we will now bring to Switzerland as well."
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Related News
15 Global Psychedelics Executives To Keep An Eye On In 2022
Marijuana Research Focuses Strictly On Potential Harms From THC, NCCIH Director Says
Medical Cannabis Company Khiron Launching New Products In Europe
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!